Ralliant Corp·4

Jun 1, 4:06 PM ET

Osben Teo 4

4 · Ralliant Corp · Filed Jun 1, 2026

Research Summary

AI-generated summary of this filing

Updated

Ralliant (RAL) CAO Osben Teo Exercises Options, Sells Shares

What Happened
Osben Teo, Chief Accounting Officer of Ralliant Corp (RAL), exercised three option tranches totaling 27,058 shares on 2026-05-28 and sold those 27,058 shares in the open market the same day. The exercises show acquisitions of 10,341 shares @ $43.33 ($448,076), 9,985 shares @ $44.58 ($445,131), and 6,732 shares @ $56.74 ($381,974) — total exercise cost ≈ $1,275,181. The subsequent open-market sale was 27,058 shares at a weighted average price of $62.44 for gross proceeds of $1,689,502, implying roughly $414,321 in proceeds after exercise costs (before taxes/fees). The filing also reports corresponding derivative disposals at $0, reflecting conversion/cancellation of the exercised options.

Key Details

  • Transaction date: 2026-05-28; Form 4 filed 2026-06-01 (timely filing).
  • Exercise details: 10,341 @ $43.33; 9,985 @ $44.58; 6,732 @ $56.74 — total cost ≈ $1,275,181.
  • Sale details: 27,058 shares sold at weighted avg $62.44 for proceeds $1,689,502; individual sale prices ranged $62.34–$62.56 (footnote).
  • Shares owned after the transaction: not specified in the provided summary.
  • Footnotes: vesting schedules noted — one option vested beginning Feb 28, 2023; another beginning Feb 27, 2024; another beginning Mar 4, 2025. Reporting person offers to provide per-price breakdown on request (F1–F4).

Context
This was an option exercise followed by an immediate sale (commonly a cashless or same-day sale), converting vested options into shares and selling them for liquidity. Such routine option-exercise sales are common for insiders to realize gains and do not by themselves indicate a change in company outlook. The insider is an executive (CAO), not a 10% owner.

Insider Transaction Report

Form 4
Period: 2026-05-28
Osben Teo
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-05-28$43.33/sh+10,341$448,07657,999 total
  • Exercise/Conversion

    Common Stock

    2026-05-28$44.58/sh+9,985$445,13167,984 total
  • Exercise/Conversion

    Common Stock

    2026-05-28$56.74/sh+6,732$381,97474,716 total
  • Sale

    Common Stock

    [F1]
    2026-05-28$62.44/sh27,058$1,689,50247,658 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F2]
    2026-05-2810,3410 total
    Exercise: $43.33Exp: 2032-02-28Common Stock (10,341 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F3]
    2026-05-289,9853,330 total
    Exercise: $44.58Exp: 2033-02-27Common Stock (9,985 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F4]
    2026-05-286,7326,733 total
    Exercise: $56.74Exp: 2034-03-04Common Stock (6,732 underlying)
Footnotes (4)
  • [F1]The price reported in Column 4 is a weighted average price rounded to the nearest hundredth. These shares were sold in multiple transactions at prices ranging from $62.34 to $62.56, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]This option vested in four annual installments beginning on February 28, 2023.
  • [F3]This option vests in four annual installments beginning on February 27, 2024.
  • [F4]This option vests in four annual installments beginning on March 4, 2025
Signature
/s/ Sarah Johnson, attorney-in-fact|2026-06-01

Documents

1 file
  • 4
    wk-form4_1780344392.xmlPrimary

    FORM 4